HK1077299A1 - Cephalosporins - Google Patents

Cephalosporins

Info

Publication number
HK1077299A1
HK1077299A1 HK05109278A HK05109278A HK1077299A1 HK 1077299 A1 HK1077299 A1 HK 1077299A1 HK 05109278 A HK05109278 A HK 05109278A HK 05109278 A HK05109278 A HK 05109278A HK 1077299 A1 HK1077299 A1 HK 1077299A1
Authority
HK
Hong Kong
Prior art keywords
cephalosporins
Prior art date
Application number
HK05109278A
Other languages
English (en)
Inventor
Gerd Ascher
Werner Heilmayer
Michael Schranz
Josef Wieser
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216418A external-priority patent/GB0216418D0/en
Priority claimed from GB0222177A external-priority patent/GB0222177D0/en
Priority claimed from GB0223975A external-priority patent/GB0223975D0/en
Priority claimed from GB0223974A external-priority patent/GB0223974D0/en
Priority claimed from GB0223977A external-priority patent/GB0223977D0/en
Priority claimed from GB0223976A external-priority patent/GB0223976D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HK1077299A1 publication Critical patent/HK1077299A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
HK05109278A 2002-07-15 2005-10-20 Cephalosporins HK1077299A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0216418A GB0216418D0 (en) 2002-07-15 2002-07-15 Organic compound
GB0222177A GB0222177D0 (en) 2002-09-24 2002-09-24 Organic compounds
GB0223975A GB0223975D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223974A GB0223974D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223977A GB0223977D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223976A GB0223976D0 (en) 2002-10-15 2002-10-15 Organic compounds
PCT/EP2003/007603 WO2004007505A1 (en) 2002-07-15 2003-07-14 Cephalosporins

Publications (1)

Publication Number Publication Date
HK1077299A1 true HK1077299A1 (en) 2006-02-10

Family

ID=30119477

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05109278A HK1077299A1 (en) 2002-07-15 2005-10-20 Cephalosporins

Country Status (23)

Country Link
US (1) US7485632B2 (no)
EP (1) EP1529050B1 (no)
JP (1) JP2005536499A (no)
KR (1) KR20050037553A (no)
CN (1) CN1678616A (no)
AR (1) AR040545A1 (no)
AT (1) ATE327239T1 (no)
AU (1) AU2003250056A1 (no)
BR (1) BR0312698A (no)
CA (1) CA2492373A1 (no)
CO (1) CO5680481A2 (no)
DE (1) DE60305506T2 (no)
EC (1) ECSP055538A (no)
ES (1) ES2268429T3 (no)
HK (1) HK1077299A1 (no)
IL (1) IL166120A0 (no)
MX (1) MXPA05000664A (no)
NO (1) NO20050781L (no)
PE (1) PE20040657A1 (no)
PL (1) PL373104A1 (no)
SI (1) SI1529050T1 (no)
TW (1) TW200422044A (no)
WO (1) WO2004007505A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000189171A (ja) * 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
CN106232576B (zh) * 2014-04-16 2019-03-01 Sika技术股份公司 含脒基或含胍基的硅烷

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5093989A (no) * 1973-10-25 1975-07-26
EP1221446B1 (en) 1995-05-11 2005-04-06 Sandoz Ag Antibacterial cephalosporins
GB0301938D0 (en) * 2003-01-28 2003-02-26 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
SI1529050T1 (sl) 2006-10-31
ECSP055538A (es) 2005-03-10
AR040545A1 (es) 2005-04-13
US7485632B2 (en) 2009-02-03
JP2005536499A (ja) 2005-12-02
CN1678616A (zh) 2005-10-05
ATE327239T1 (de) 2006-06-15
EP1529050B1 (en) 2006-05-24
DE60305506D1 (de) 2006-06-29
WO2004007505A1 (en) 2004-01-22
BR0312698A (pt) 2005-05-03
PL373104A1 (en) 2005-08-08
CA2492373A1 (en) 2004-01-22
MXPA05000664A (es) 2005-04-25
PE20040657A1 (es) 2004-11-08
CO5680481A2 (es) 2006-09-29
AU2003250056A1 (en) 2004-02-02
IL166120A0 (en) 2006-01-15
ES2268429T3 (es) 2007-03-16
TW200422044A (en) 2004-11-01
EP1529050A1 (en) 2005-05-11
NO20050781L (no) 2005-02-14
KR20050037553A (ko) 2005-04-22
DE60305506T2 (de) 2007-04-19
US20050234233A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
HUS1600008I1 (hu) Cefémvegyületek
DE50311874D1 (en) Spirocyclische cyclohexan-derivate
DE50312422D1 (en) Aryloxime
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
DE60303791D1 (en) Aza-arylpiperazine
DE50309217D1 (en) Benzimidazolderivate
AU2003252028A8 (en) Heterodiamondoids
AU2003279495A8 (en) Alert-modeling
DE50308027D1 (en) Cyclohexyl-harnstoff-derivate
DE50313444D1 (en) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
DE50307787D1 (en) Isophthalsäurederivate
DE50312412D1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivative
DE50311133D1 (en) Carbonsäureamide
DE60224584D1 (en) Rotationsdämpfer
DE50310169D1 (en) Lingual-retainer
DE60310887D1 (en) Epilatorstreifen
AU2003264900A8 (en) Cast-cutter
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
DE50304964D1 (en) Handhobelmaschine
AU2003262681A8 (en) Hemo-aide
HK1077299A1 (en) Cephalosporins
AU2003253735A8 (en) Vacuolins
AU2002341221A8 (en) Honey-brandy
DE50309021D1 (en) Etherlacton

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100714